In summary, using a series of bioinformatics and retrospective analyses, the present study identified a subset of seven genes (CDC20, CDKN2A, CTSV, FOXM1, KRT23, MAGEA6, and S100A9), which were significantly associated with progression and prognosis of bladder cancer. This evidence concerns the gene CDC20 and urinary bladder cancer.